Qbtech provides objective data when diagnosing or treating patients with ADHD, adding depth to the diagnosis and facilitating the evaluation of treatment.
Qbtech has raised €15M across 1 funding round from 1 investor, most recently a round in Aug 2022. Based in Stockholm, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-30 | Other | €15M |
| Verdane |
| View deal → |
